Eton Pharma COO Danka Radosavljevic files initial beneficial ownership statement
ETON•Form 3 filing reports common shares held directly
- Eton Pharmaceuticals COO Danka Radosavljevic filed a Form 3 reporting 22,473 common shares held directly as of July 31, 2026.
